Latest Overactive Bladder News
Potentially inappropriate medication use is prevalent in older adults undergoing antimuscarinic treatment for overactive bladder.
Patients' median bladder capacity improved from 150 to 200 mL and continence improved in nearly 90% of patients.
Researchers also find a significant association between smoking and secondary nocturnal enuresis.
A high cure rate was observed in women with de novo OAB symptoms following transobturator tape surgery.
Symptom improvement was greater in patients receiving tamsulosin plus darifenacin compared with tamsulosin monotherapy.
Adding vaginal estrogen may sustain the effects.
Among seniors with severe overactive bladder, a combination of solifenacin and mirabegron decreased incontinence by an average 3.5 episodes a day.
The number of neuromodulation test procedures performed per physician has increased.
Small reductions in urge incontinence episodes, voids per day with daily dose of medications.
A study found that 33.8% of women received anticholinergics compared with 19.4% of men.
OAB treatment is associated with a decreased risk of falls, study finds.
Regardless of delivery type, obesity ups the risk of more severe urinary symptoms, study shows.
In a study, severe nocturia predicted increased mortality risk.
Elderly patients with OAB may benefit from combined high-dosage antimuscarinics.
Repeat injections of onabotulinumtoxinA (BTXA) appear to benefit patients with non-neurogenic overactive bladder.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)